Explore Top Tech Companies
All Filters
Location

Remote jobs

Industry

DEI

Tech Stack

Perks

Size

Top Fully Remote Biotech Companies (65)

Don't see your company?

Create a company profile
Gaming • Healthtech • Other • Biotech
Fully Remote
14,500 Employees

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and know-how to help improve people’s hearing and health. In every aspect, from hearing devices, hearing implants and diagnostic equipment to hearing care all over the world, Demant is active and engaged. A growing business in intelligent audio solutions for gaming and office communication is also a significant part of the Group. The Demant Group operates in a global market with companies in more than 30 countries, employs more than 14,500 staff and generates annual revenue of DKK 14 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health. Listed on the Nasdaq Copenhagen stock exchange as one of the 25 most traded shares in terms of free floated market capitalisation, also known as the C25 index, Demant is the parent company behind the commercial successes of such world-renowned brands as Oticon, Bernafon, Sonic, Audika, Oticon Medical, MAICO, Interacoustics, Amplivox, Grason-Stadler, MedRx and Sennheiser Communications. William Demant Invest A/S, a company wholly owned by William Demant Foundation, holds the majority of shares in Demant A/S, providing stability and strength for the long haul.


Healthtech • Biotech • Pharmaceutical
Fully Remote
2,246 Employees

Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.5 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.


Biotech
Fully Remote
289 Employees

Climate change is the challenge of our generation. As innovators, we believe disruptive technology can bring performant solutions to the most dire challenges we face as a society. As we seek a more respectful way of living on our planet, nature itself has much to offer and teach us, starting with feeding the world of tomorrow with better nutrients - for animals, people and our planet - through insects. At Innovafeed, we are committed to inventing efficient technologies that reproduce Nature's processes on a large scale. By building a circular and zero waste agri-food chain replicating insect's role in nature, we want to reinvent our way of living with higher quality, sustainability and resilience, for everyone. We are a team of pragmatic dreamers who believe performance and positive impact can go hand in hand to reshape the world we leave to future generations.


Biotech • Pharmaceutical
Fully Remote
93 Employees

Causaly amplifies human cognitive abilities to expand the boundaries of discovery towards making the best decisions in Biomedicine. To achieve this, we are teaching computers to read all knowledge ever published and develop an interface that allows humans to answer questions they can’t ask anywhere else.


Biotech
Fully Remote
68 Employees

Please note that this company page is no longer updated. Meet us at https://www.linkedin.com/company/bio-rad-antibodies. As of May 17 2016, AbD Serotec, a Bio-Rad company changed its name to Bio-Rad. Following this re-branding, we created a new LinkedIn showcase page that features all the latest news, updates and useful resources from the antibody team at Bio-Rad. Please follow us on this new page (https://www.linkedin.com/company/bio-rad-antibodies) to keep in touch with us on LinkedIn.


Biotech
Fully Remote
55 Employees

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previously possible. We’re building a first-in-kind platform designed to sit at the intersection of RNA technology delivery methods, data science and automation to develop an expansive portfolio of medicines, initially focused in the areas of vaccines, immunomodulation, protein replacement and regenerative medicine. Founded by experts in the fields of genetic medicine and RNA development and delivery, we have a dynamic operational structure designed to harness the ingenuity of a deep and diverse team of scientists, drug developers and business leaders.


Healthtech • Biotech
Fully Remote
154 Employees

Parachute is a new kind of plasma donation company that allows individuals to earn money while creating life-saving medicine. Plasma is used to create medicine that treats chronic illnesses, including immune disorders, liver disease, bleeding disorders, and cancer. Right now, there’s a severe plasma shortage, which is impacting patients’ access to these life-saving treatments


Biotech
Fully Remote
90 Employees

Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.


Biotech
Fully Remote
280 Employees

Altos Labs™ is a biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. The company comprises a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission. Altos has operations in the San Francisco Bay Area and San Diego, and in Cambridge, UK, with significant collaborations in Japan. Note: Altos Labs will not ask you to download a messaging app for an interview or outlay your own money to get started as an employee. If this sounds like your interaction with people claiming to be with Altos, it is not legitimate and has nothing to do with Altos.


Biotech • Pharmaceutical
Fully Remote
834 Employees

Ascendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients’ lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon technologies to create new and potentially best-in-class therapies. Ascendis Pharma currently has a pipeline of three independent endocrinology rare disease product candidates and one oncology product candidate in clinical development. The company continues to expand into additional therapeutic areas to address unmet patient needs. Ascendis is headquartered in Copenhagen, Denmark, with additional offices in Heidelberg and Berlin, Germany, Palo Alto and Redwood City, California, and Princeton, New Jersey.


Biotech • Agriculture
Fully Remote
34 Employees

Okanagan Specialty Fruits (OSF) began as a small, dynamic agricultural biotechnology company based in Summerland, British Columbia, Canada. Founded in 1996, OSF specializes in developing tree fruit varieties with novel attributes that benefit fruit producers and consumers alike. OSF is one of the first firms to pursue the use of biotechnology to deliver product innovations to the tree fruit industry. Our Leadership OSF is led by apple and cherry grower Neal Carter. Through his work across the globe as a bioresource engineer, Neal became convinced of the opportunities offered by biotechnology. OSF’s world-class science team works collaboratively with many of the world’s leading tree fruit research institutions. Our Vision OSF will change the way people think about and experience produce; our creative product development and commercialization expertise will open the door to novel, exciting, specialized foods that support the evolving healthy diet choices of today’s consumer. Our Mission To develop safe, high-quality tree fruit cultivars that provide growers, processors, wholesalers, retailers, foodservice and consumers with improvements in quality and productivity; and to successfully market and commercialize these products. A revolutionary innovation: Arctic® apples OSF’s flagship project is the development and commercialization of nonbrowning Arctic® apples. Arctic® apples’ nonbrowning trait offers valuable benefits for all members of the apple supply chain, from growers to consumers. OSF holds a worldwide license on the ability to regulate the expression of polyphenol oxidase (PPO) genes to control enzymatic browning in tree fruits, and we are patent holders of the technology that enables us to do so. By reducing the expression of PPO, OSF is developing tree fruits with inhibited enzymatic browning.


Healthtech • Biotech • Pharmaceutical
Fully Remote
100 Employees

Lightship is your complete solution for decentralized clinical trials. We built our virtual-first clinical trial model from the ground up, allowing patients to participate in clinical trials from the comfort of home. Come join the team perfecting the way clinical trials are done!


Healthtech • Software • Database • Biotech • Pharmaceutical
Fully Remote
300 Employees

OneStudyTeam, a member of the Reify Health family, provides the cloud-based platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows online and enables sites, sponsors, and other key stakeholders to work together more effectively using common technology. The suite of StudyTeam solutions reduces site burden and helps sites pre-screen and enroll more patients, provides sponsors with end-to-end visibility into recruitment activity across all channels, and guides sites in conducting the trial for patients who have been enrolled. StudyTeam is trusted by the largest global biopharmaceutical companies, used in over 5,000 research sites, and is available in over 100 countries. One mission. One team. That’s OneStudyTeam


Biotech
Fully Remote
167 Employees

AB Enzymes is an industrial biotech company specialized in enzymes and their applications. The company is part of Associated British Foods and represented worldwide. Our offices are located in Brazil, China Germany, Finland, Singapore and USA. Our products range from food grade enzymes for baking and beverages, grains and vegetable oil seeds processing, to enzymes for animal feed and technical applications: pulp & paper, textiles and laundry detergents. We partner with our diverse and unique customers to support them in their process optimization needs.


Healthtech • Biotech
Fully Remote
93 Employees

Apogee Therapeutics, LLC is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological and inflammatory disorders


Biotech
Fully Remote
15 Employees

° Mycelium production Mycelia produces and commercializes mycelium. From our large collection of strains, we produce mother cultures, mother spawn and spawn which are sold all over the world. °Mycelia School Our long standing experience and solid scientific basis in mycelium production, enabled us to create the Mycelia School. We offer trainings on spawn production, sterilised substrate and lignicolous mushroom production and lab design. °R&D We are also involved in a number of R&D activities in view of constant improvement of its production. Our main R&D focus is the development of new species and maintenance of existing species in a structural research basis.


Biotech
Fully Remote
107 Employees

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.


Artificial Intelligence • Software • Biotech • Pharmaceutical
Fully Remote
326 Employees

BenchSci’s vision is to bring novel medicine to patients 50% faster by 2025. To achieve this, we're exponentially increasing the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient Ventures (Google’s AI fund), Inovia Capital, and TCV, our platform accelerates science at 16 of the top-20 pharmaceutical companies, and over 4,300 leading research centers worldwide. We’re a remote-first company recognized for our impact and culture as a Deloitte Tech Fast 50TM, CIX Top 10 Growth, Great Place to Work®, and top-ranked organization on Glassdoor.


Biotech
Fully Remote
20 Employees

Trialwise is a woman-owned, boutique clinical research organization (CRO) specializing in early phase clinical studies and niche consulting. We intentionally partner with a limited number of biotech and pharma clients to offer a customized approach to managing projects efficiently without compromising quality, accuracy, or adherence to protocol and regulatory compliance. Since our inception, Trialwise has operated as a decentralized team working cross-functionally in an environment unencumbered by silos and bureaucracy. Our collaborative approach with our clients ensures we deliver the quality, personal attention, and cost efficiencies on which Trialwise has built its reputation. Trialwise president, Beth Brinsdon, founded the company in 1999 after two decades in the pharmaceutical industry. She observed that start-up and small-to-midsize biotech companies in the early stages of drug development require a high level of personalized service, a level that can be best provided by a small CRO. In 2015, she renamed the company to Trialwise and began scaling operations with a remote team to collaborate with select clients ranging from start-ups to established bio-pharma companies. The Trialwise approach is attentive, flexible, proactive, and committed to the highest quality industry standards in the following areas: - Protocol Development - Site Qualification - Risk Identification and Assessment - Study Start-up - Database Development and Management - Risk-based Management - Traditional Monitoring - Statistical Programming of CDISC Compliant Datasets - Statistical Analysis - Quality Assurance Oversight - Clinical Study Report Development - Document Processing and eCTD Compliant Granular ePub - Clinical Trial Registration and Results Disclosure - Staffing Support


Artificial Intelligence • Machine Learning • Software • Biotech • Pharmaceutical
Fully Remote
10 Employees

BioReact leverages the power of artificial intelligence and machine learning to help with design of experiment (DOE) and optimizing the parameters to help your cells reach their full potential.